Deregulation of CCND1 was observed frequently in numerous human cancers, including pancreatic cancer, head and neck squamous cell carcinoma, breast cancer, and colorectal carcinoma [36, 37]. This evidence concerns the gene CCND1 and head and neck squamous cell carcinoma.